These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 32486505)

  • 1. Metabolic Escape Routes of Cancer Stem Cells and Therapeutic Opportunities.
    Turdo A; Porcelli G; D'Accardo C; Franco SD; Verona F; Forte S; Giuffrida D; Memeo L; Todaro M; Stassi G
    Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Stem Cells: Metabolic Characterization for Targeted Cancer Therapy.
    Kaur J; Bhattacharyya S
    Front Oncol; 2021; 11():756888. PubMed ID: 34804950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Stem Cell Metabolism and Potential Therapeutic Targets.
    Snyder V; Reed-Newman TC; Arnold L; Thomas SM; Anant S
    Front Oncol; 2018; 8():203. PubMed ID: 29922594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and opportunities for cancer stem cell-targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell-dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes.
    Alqarni A; Jasim SA; Altalbawy FMA; Kaur H; Kaur I; Rodriguez-Benites C; Deorari M; Alwaily ER; Al-Ani AM; Redhee AH
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23719. PubMed ID: 38764138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Targeting of Cancer Stem Cells.
    Mukha A; Dubrovska A
    Front Oncol; 2020; 10():537930. PubMed ID: 33415069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidimensional analysis of tumor stem cells: from biological properties, metabolic adaptations to immune escape mechanisms.
    Han H; He T; Wu Y; He T; Zhou W
    Front Cell Dev Biol; 2024; 12():1441081. PubMed ID: 39184916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Oxidative Phosphorylation on Cancer Drug Resistance.
    Zhao Z; Mei Y; Wang Z; He W
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
    Zhu Y; Li X; Wang L; Hong X; Yang J
    Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Emerging Role of Tumor Microenvironmental Stimuli in Regulating Metabolic Rewiring of Liver Cancer Stem Cells.
    Correnti M; Binatti E; Gammella E; Invernizzi P; Recalcati S
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma.
    Shen YA; Wang CY; Hsieh YT; Chen YJ; Wei YH
    Cell Cycle; 2015; 14(1):86-98. PubMed ID: 25483072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic crosstalk in the breast cancer microenvironment.
    Dias AS; Almeida CR; Helguero LA; Duarte IF
    Eur J Cancer; 2019 Nov; 121():154-171. PubMed ID: 31581056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Energy metabolism in cancer stem cells.
    Zhu X; Chen HH; Gao CY; Zhang XX; Jiang JX; Zhang Y; Fang J; Zhao F; Chen ZG
    World J Stem Cells; 2020 Jun; 12(6):448-461. PubMed ID: 32742562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.
    Ahmed N; Escalona R; Leung D; Chan E; Kannourakis G
    Semin Cancer Biol; 2018 Dec; 53():265-281. PubMed ID: 30317036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression.
    Yang E; Wang X; Gong Z; Yu M; Wu H; Zhang D
    Signal Transduct Target Ther; 2020 Oct; 5(1):242. PubMed ID: 33077737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment.
    Gaggianesi M; Di Franco S; Pantina VD; Porcelli G; D'Accardo C; Verona F; Veschi V; Colarossi L; Faldetta N; Pistone G; Bongiorno MR; Todaro M; Stassi G
    Front Oncol; 2021; 11():702642. PubMed ID: 34354950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Profiles of Cancer Stem Cells and Normal Stem Cells and Their Therapeutic Significance.
    Stouras I; Vasileiou M; Kanatas PF; Tziona E; Tsianava C; Theocharis S
    Cells; 2023 Nov; 12(23):. PubMed ID: 38067114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Therapies Targeting Metabolic Pathways in Cancer Stem Cells.
    Shen YA; Chen CC; Chen BJ; Wu YT; Juan JR; Chen LY; Teng YC; Wei YH
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linking Tumor Microenvironment to Plasticity of Cancer Stem Cells: Mechanisms and Application in Cancer Therapy.
    Zheng X; Yu C; Xu M
    Front Oncol; 2021; 11():678333. PubMed ID: 34262865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functions of Key Enzymes of Glycolytic Metabolism in Tumor Microenvironment.
    Xu W; Weng J; Xu M; Zhou Q; Liu S; Hu Z; Ren N; Zhou C; Shen Y
    Cell Reprogram; 2023 Jun; 25(3):91-98. PubMed ID: 37172278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.